New variant Creutzfeldt-Jakob disease: a controversial but potential blood transfusion risk.
作者信息
Basu Amitabha
机构信息
Manipal College of Medical Sciences, Pokhara, P.O. Box: 155, Nepal.
出版信息
Nepal Med Coll J. 2003 Jun;5(1):51-2.
PMID:16583978
Abstract
摘要
相似文献
1
New variant Creutzfeldt-Jakob disease: a controversial but potential blood transfusion risk.
Nepal Med Coll J. 2003 Jun;5(1):51-2.
2
Blood-transmitted prions and variant Creutzfeldt-Jakob disease.
Biologicals. 2007 Apr;35(2):75-7. doi: 10.1016/j.biologicals.2007.01.005. Epub 2007 Feb 20.
3
Creutzfeldt-Jakob disease and blood products: FDA policy.
Biologicals. 1998 Jun;26(2):133-4. doi: 10.1006/biol.1998.0131.
4
Variant Creutzfeldt-Jakob disease and prions in the blood supply.
Clin Adv Hematol Oncol. 2004 Feb;2(2):84, 87, 131.
5
Variant Creutzfeldt-Jacob disease - the availability of a screening test will be the beginning, not the end, of difficult transfusion-related issues.
Curr Opin Hematol. 2006 Nov;13(6):445-6. doi: 10.1097/01.moh.0000245693.39709.fa.
6
An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
Br J Haematol. 2009 Jan;144(1):14-23. doi: 10.1111/j.1365-2141.2008.07376.x. Epub 2008 Oct 17.
7
Impact of vCJD on blood supply.
Biologicals. 2007 Apr;35(2):79-97. doi: 10.1016/j.biologicals.2007.01.002. Epub 2007 Feb 21.
8
Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
Transfusion. 2009 May;49(5):977-84. doi: 10.1111/j.1537-2995.2008.02056.x. Epub 2009 Jan 5.
9
Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
Br J Haematol. 2006 Jan;132(1):13-24. doi: 10.1111/j.1365-2141.2005.05796.x.
10
Implications of notifying donors and recipients.
Vox Sang. 2004 Jul;87 Suppl 2:1-2. doi: 10.1111/j.1741-6892.2004.00442.x.
Zotero 插件